Epigallocatechin‐3‐gallate inhibited cancer stem cell–like properties by targeting hsa‐mir‐485‐5p/RXRα in lung cancer
Year: 2018
Type: article
Source: Journal of Cellular Biochemistry
DOI: 10.1002/jcb.27117
Institution: Nanjing Medical University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Award: G4747437994
OpenAlex ID: W2886202166
